Latest News

Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Employee Well-Being: A Commitment that Defines Richmond

October 2023

Dr. Junko Ono, the Occupational Support Manager at Richmond Pharmacology provides her insights on fostering a positive work environment.

View article

Promising Results for Zilebesiran in Phase 1 Study

September 2023

We are pleased to share the findings from our recent Phase 1 study, which investigated the potential of Zilebesiran, an investigational RNA interference therapeutic.

View article

Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery

September 2023

Discover how Richmond's dedicated team of volunteers is making a positive impact on young minds at Arc Nursery

View article

Exciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors

September 2023

We’re excited to share the findings of our recent study on the use of auto-injector systems (A-INJ) in randomized controlled trials (RCTs) by Dr Jorg Taubel, Dr Ulrike Lorch, Dr Thomas York and Vishal Aggarwal.

View article

Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension

July 2023

Our research on behalf of Anylam Pharmaceuticals for a novel anti-hypertensive injectable, Zilbesiran, has been featured in the prestigious New England Journal of Medicine.

View article

James Rickard appointed Chief Scientific Officer of Richmond Research Institute

June 2023

James Rickard is a Research Pharmacist and has been involved in translational research to deliver new therapeutic options to patients throughout his career. Driven by his desire for better outcomes for patients, he spent his early career working across several London Teaching Hospitals in Clinical Pharmacy, Drug Manufacture and Clinical Trials, culminating in taking up the role of Deputy Chief Pharmacist for Barts Health NHS Trust.

View article

Low data variability

Exceptional ECG generation

Experts in cardiac safety

Our specialist services

News

Stay up to date with the latest activity at Richmond Pharmacology

Employee Well-Being: A Commitment that Defines Richmond

Promising Results for Zilebesiran in Phase 1 Study

Engaging Hearts and Hands: A Day of Volunteering at Arc Nursery

Exciting Research Update: Enhancing Blinding in Clinical Trials with Auto-Injectors

Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension

James Rickard appointed Chief Scientific Officer of Richmond Research Institute

主要メンバー紹介

リッチモンドでのキャリア

動画紹介

Richmond Strengthens ESG Commitment Through Sustainability Accelerator Programme

Trial That Could Revolutionise Cardiac Safety Studies – Research Consortium Calls For Others To Join

Events

CRISPR Medicine 2025: Unlocking Gene-Editing Potential

私たちについて

ナレッジベース

ソーシャルメディア